University Of Maryland, Baltimore
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 1807-01-01
- Employees
- 7.3K
- Market Cap
- -
- Website
- http://www.umaryland.edu
GLP-1 and Hypoglycemia
- Conditions
- Type 2 Diabetes Mellitus
- Interventions
- Drug: Glucagon-Like Peptide- 1 (GLP-1) infusion
- First Posted Date
- 2013-05-21
- Last Posted Date
- 2024-03-06
- Lead Sponsor
- University of Maryland, Baltimore
- Target Recruit Count
- 28
- Registration Number
- NCT01858896
- Locations
- 🇺🇸
University of Maryland, Baltimore, Baltimore, Maryland, United States
Tobacco Craving and Triggers in Persons With Schizophrenia
- Conditions
- SmokerSchizophrenia Diagnosis
- First Posted Date
- 2013-05-03
- Last Posted Date
- 2019-09-25
- Lead Sponsor
- University of Maryland, Baltimore
- Target Recruit Count
- 45
- Registration Number
- NCT01846065
- Locations
- 🇺🇸
Maryland Psychiatric Research Center, Catonsville, Maryland, United States
Phase II Trial of Low-Dose Whole Brain Radiotherapy With Concurrent Temozolomide and Adjuvant Temozolomide in Patients With Newly-Diagnosed Glioblastoma Multiforme
- Conditions
- Histologically Proven Diagnosis of Glioblastoma or Gliosarcoma (WHO Grade IV)
- Interventions
- Drug: Chemotherapy with Temodar.Radiation: Radiation therapy
- First Posted Date
- 2013-04-02
- Last Posted Date
- 2022-12-29
- Lead Sponsor
- University of Maryland, Baltimore
- Target Recruit Count
- 24
- Registration Number
- NCT01822275
- Locations
- 🇺🇸
Ummc Msgcc, Baltimore, Maryland, United States
The Family VOICE Study
- Conditions
- AutismAggressionPsychotic DisordersBipolar Disorder
- Interventions
- Other: Family Navigator consultation
- First Posted Date
- 2013-03-05
- Last Posted Date
- 2019-11-20
- Lead Sponsor
- University of Maryland, Baltimore
- Target Recruit Count
- 350
- Registration Number
- NCT01804582
- Locations
- 🇺🇸
University of Maryland, School of Medicine, Department of Psychiatry, Division of Child and Adolescent Psychiatry, Baltimore, Maryland, United States
Focal Therapy for Prostate Cancer
- Conditions
- Prostate CancerProstatic Neoplasms
- Interventions
- Radiation: Brachytherapy
- First Posted Date
- 2013-03-01
- Last Posted Date
- 2021-05-11
- Lead Sponsor
- University of Maryland, Baltimore
- Registration Number
- NCT01802307
- Locations
- 🇺🇸
University of Maryland School of Medicine, Baltimore, Maryland, United States
Improving Community Ambulation After Hip Fracture
- Conditions
- Hip Fracture
- Interventions
- Dietary Supplement: NutritionBehavioral: PULSEBehavioral: PUSH
- First Posted Date
- 2013-02-05
- Last Posted Date
- 2022-01-27
- Lead Sponsor
- University of Maryland, Baltimore
- Target Recruit Count
- 210
- Registration Number
- NCT01783704
- Locations
- 🇺🇸
University of Connecticut Health Center, Farmington, Connecticut, United States
🇺🇸Dartmouth Medical School, Lebanon, New Hampshire, United States
🇺🇸University of Maryland, Baltimore, Baltimore, Maryland, United States
Trial of Intravenous Azithromycin to Eradicate Ureaplasma Respiratory Tract Infection in Preterm Infants
- First Posted Date
- 2013-01-29
- Last Posted Date
- 2020-11-30
- Lead Sponsor
- University of Maryland, Baltimore
- Target Recruit Count
- 121
- Registration Number
- NCT01778634
- Locations
- 🇺🇸
Christiana Care Health Services, Newark, Delaware, United States
🇺🇸University of Maryland School of Medicine, Baltimore, Maryland, United States
🇺🇸Johns Hopkins University, Baltimore, Maryland, United States
Effects of Hesperidin on Insulin Sensitivity
- First Posted Date
- 2013-01-23
- Last Posted Date
- 2022-03-04
- Lead Sponsor
- University of Maryland, Baltimore
- Registration Number
- NCT01773486
- Locations
- 🇺🇸
University of Maryland, Baltimore, Maryland, United States
Chitosan Chewing Gum Study in Dialysis Patients
- Conditions
- End Stage Renal Disease
- Interventions
- Dietary Supplement: Chitosan
- First Posted Date
- 2013-01-17
- Last Posted Date
- 2021-06-23
- Lead Sponsor
- University of Maryland, Baltimore
- Target Recruit Count
- 15
- Registration Number
- NCT01770470
- Locations
- 🇺🇸
University of Maryland, Baltimore, Maryland, United States
MRI for Eval Tumor & Node Response & Normal Tissue Function to Concurrent Chemo & Radiation Therapy in H&N Cancer (GCC1043)
- Conditions
- Head and Neck Cancer
- First Posted Date
- 2013-01-15
- Last Posted Date
- 2019-09-12
- Lead Sponsor
- University of Maryland, Baltimore
- Target Recruit Count
- 30
- Registration Number
- NCT01768442
- Locations
- 🇺🇸
University of Maryland Medical Center, Baltimore, Maryland, United States